Coverage With Evidence Development
Ethical Issues and Policy Implications
Datos Bibliográficos
| ID | 9104825 |
|---|---|
| Autores | Franklin G Miller (0000-0001-5942-1991, National Institutes of Health), Steven D Pearson (National Institutes of Health) |
| Año | 2008 |
| Volumen | 46 |
| Número | 7 |
| Páginas | 746-751 |
| Fecha de publicación | 2008-07-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | Medical Care (JOURNAL) |
| Identificadores de la revista | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editorial | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/mlr.0b013e3181789453 |
| PMID | 18580395 |
| OpenAlex | W2170200321 |
| Idioma | EN |
| Referencias citadas | 18 |
Coverage with evidence development (CED) is an evolving method of providing provisional access to novel medical interventions while generating the evidence needed to determine whether unconditional coverage is warranted. In this article we review the policy rationale for CED and present a normative analysis that addresses ethical concerns and policy implications
MEDLINE · Normative · Policy development · Political science · Psychological intervention · Health Systems, Economic Evaluations, Quality of Life · Healthcare cost, quality, practices · Healthcare Policy and Management · Law · Medicine · Nursing · Psychology · Public Administration
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |